Spring 2013

The NLA has consistently held a determined focus on promoting the highest levels of education and professional development. We are defined by the quality of our outstanding leadership, members, partners and staff. As a result, we are continuously challenged to assess and refine our work in an... more

0
No votes yet

I am pleased to present to the National Lipid Association the Spring 2013 issue of the Lipid Spin. The Pacific Lipid Association serves the states of Washington, Oregon, California, Idaho, Montana, Nevada, Utah, Alaska, and Hawaii. The theme of this Spring issue is "Roles of Common... more

0
No votes yet

...the times they are a-changin' ~Bob Dylan These are exciting times for Lipidologists! We can always count on change as the one sure thing in life. Our field is changing. As health care evolves, the NLA is doing its part to position our field to take advantage of the changes that our system... more

5
Average: 5 (1 vote)

The year 2013 marks the "Silver Anniversary" of three key announcements that identified relationships among various lipid fractions, lipoproteins, apolipoproteins, non-lipid disorders and cardiovascular disease (CVD) risk. In 1988, NCEP ATP I1 recognized evidence that high levels of low... more

5
Average: 5 (1 vote)

Remnant Lipoproteins Promote Foam Cell Formation Atherosclerosis is characterized by accumulation of inflammatory foam cells whose formation is promoted by the subendothelial retention of ApoBcontaining lipoproteins. Plaques develop in predisposed areas of the arterial tree where blood flow is... more

0
No votes yet

Recent high-profile interventional studies and a large genetic association analysis have failed to show a benefit of raising high density lipoprotein cholesterol (HDL-C) levels on cardiovascular disease (CVD) outcomes, calling into question the validity of the HDL hypothesis. Among several... more

5
Average: 5 (1 vote)

Coronary heart disease (CHD) remains the leading cause of death in Western civilizations. The role of abnormal lipid metabolism as a modifiable risk factor for CHD is well documented. The presence of chronic kidney disease (CKD) is also associated with an increased risk of CHD, but the pathogenesis... more

5
Average: 5 (1 vote)

It is typically silent, but sometimes you can hear it, a soft systolic ejection murmur heard over the aortic area during cardiac auscultation on physical examination. As cardiovascular risk reduction specialists, we do not to want to miss this cardiac murmur. It is not innocent or benign; this is... more

5
Average: 5 (1 vote)

As President-elect of the Pacific Lipid Association, it gives me a great pleasure to present our chapter update. Our members continue to be very active in their communities as well as throughout the NLA. Our own Matthew Ito, PharmD, will become the NLA President this May. March of last year, our... more

5
Average: 5 (1 vote)

Following the Foundation of the NLA’s inaugural Familial Hypercholesterolemia Roundtable in New Orleans this past February, I am pleased to report meaningful progress on our important FH initiative. We convened with an outstanding delegation of representatives from the American College of... more

5
Average: 5 (1 vote)